NASDAQ · Financial Statements
Propanc Biopharma, Inc. (PPCB) Financial Statements
$0.47
NASDAQ: PPCB
Market Cap $1.07M
Overview Financials Dividend Propanc Biopharma, Inc. most recently reported annual revenue of $0, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2022 2023 2024 2025 2026 Revenue $0 $0 $0 $0 $0 Operating Profit $-2.0M $-2.0M $-2.0M $-57.0M $-18.0M Net Profit $-3.0M $-3.0M $-2.0M $-59.0M $-19.0M EPS $-27986891.75 $-781709.75 $-30000.00 $-371.25 $-17.62 Op Margin — — — — —
Balance Sheet (USD)
Metric 2022 2023 2024 2025 2026 Total Assets $0 $0 $0 $20.0M $13.0M Total Liabilities $3.0M $3.0M $4.0M $6.0M $3.0M Cash $0 $0 $0 $0 $1.0M Borrowings $1.0M $1.0M $1.0M $2.0M $0
Cash Flow (USD)
Metric 2022 2023 2024 2025 2026 Operating Cash Flow $-1.0M $-1.0M $-1.0M $0 $-6.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $1.0M $0 $1.0M $0 $1.0M Net Cash Flow $0 $0 $0 $0 $1.0M Free Cash Flow $-1.0M $-1.0M $-1.0M $0 $-6.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.05 FCF Yield -500.60% Quick Ratio 2.55 Interest Coverage -42.24 Return 1Y -98.67% Return 3Y -65.47% Return 5Y -99.93%
Screens featuring this stock